by rss feed | Aug 6, 2023 | biocardia, MSC, MSCs Mesenchymal stem stromal cells, News Feeds, weekly reads
A days ago the news came about Mesoblast not getting FDA approval for its MSC product for GvHD. The MSC area has had a rough few years with various clinical trials including for COVID. The “stem cells for heart disease” arena has also had a tough time....
